Clinical Trials Browser

NIH × tanespimycin × Plasma cell × Clear all

NCT00303797 2013-03-19

Sorafenib and Bortezomib in Treating Patients With Advanced Cancer

Phase 1 Completed

LymphoidOther hematologic neoplasmPlasma cell

Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell